SystemAge 2.1: The First Biological Age Test with Separate Male and Female Models
BiohackingBiological age tests have always claimed to measure how fast you’re aging — but they’ve measured men and women with the same model. Generation Lab’s SystemAge 2.1 is the first platform to run dedicated male and female algorithms across all 21 organ systems it tracks.
What Makes It Different
Launched June 25, 2026, SystemAge 2.1 analyzes over 460 biomarkers across 21 organ systems, with the v2.1 update adding coverage for skin and connective tissue, the reproductive system, and mitochondrial function. The gender-specific layer adds separate male and female models across all tracked systems — recognizing that aging presents differently at the molecular level between sexes in ways a unified composite score masks.
Generation Lab uses a “Biological Noise” metric — measuring the standard deviation of DNA methylation rather than a traditional linear methylation clock. The company reports 99% accuracy validated across 1,605 test cases, and the platform supports longitudinal tracking, enabling clinicians to monitor per-organ treatment efficacy across visits.
Published outcomes in the source population include average 5.5-year biological age reductions following stem cell protocols and 10.4-year immune system improvements after therapeutic plasma exchange. These figures describe what was measured in specific clinical cohorts under structured interventions — not outcomes individuals should expect without supervised protocols.
Why This Category / Comparison Matters
Most biological age tests on the market produce a single composite score. Even sophisticated methylation clocks like Horvath’s generate one number that flattens organ-level differences. SystemAge 2.1 breaks biological age down by individual organ system and now by sex, which matters because hormonal dynamics, reproductive aging, and metabolic trajectories diverge significantly between men and women in ways that a single aggregate score cannot surface.
The platform deploys through clinical partners rather than direct-to-consumer: currently available via 750+ partner clinics across 18 countries, with a needle-free blood draw and clinician-interpreted results. It’s built for longevity clinics running structured protocols, not self-directed biohackers using at-home kits.
The Catch / Who It’s For
SystemAge 2.1 has no published retail pricing, and access is gated through Generation Lab’s clinic partner network. The needle-free blood draw and the onboarding process for new clinical partners suggest this is aimed at practices that interpret results in therapeutic context — not a self-tracker tool.
The gender-specific improvement is meaningful but incremental relative to what’s already available. Comparable methylation clocks have added sex-adjusted models in recent versions. What differentiates SystemAge 2.1 is the organ-system granularity and the Biological Noise metric — not the gender adjustment alone.
The So What
For longevity clinics running structured interventions — stem cell protocols, therapeutic plasma exchange, peptide regimens — SystemAge 2.1 offers the most granular organ-system tracking currently available, with sex-appropriate baselines for each system. The real asset for practitioners is the longitudinal per-organ monitoring dashboard: it turns a static biological age score into a treatment efficacy tracking system. If you’re working with a longevity clinic, it’s worth asking whether they’ve adopted the v2.1 update.
Source: Longevity.Technology
Content created with AI assistance and reviewed for accuracy.
Join the conversation
Stack Insiders is our free community for readers who want to go deeper — share resources, ask questions, and connect with others across every vertical we cover.
Join Stack Insiders →